Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04112953 · ClinicalTrials.gov registry record
Intraoperative Transesophageal Echocardiography Assessment of Portal Vein Flow and Renal Resistive Index As a Predictor of Acute Kidney Injury After Cardiac Surgery: A Prospective Observational Study
A clinical trial of AKI, sponsored by University of Chicago.
- Completed
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT04112953 is a study of AKI that has completed, run by University of Chicago. The registered enrollment target is 80 participants, above the 72-participant average among 4 other AKI trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04112953, a study of AKI, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to better understand if transesophageal echocardiography during cardiac surgery can predict problems with kidney function after cardiac surgery.
Conditions Studied
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2019-09-04 |
| Est. Completion | 2022-11-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04112953
The ClinicalTrials.gov registry entry for NCT04112953 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 72-participant average among 4 other AKI trials with a reported enrollment target (11% higher). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with AKI appearing as the primary indexed condition, and to 0 interventions.
NCT04112953 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT04112953 about?
NCT04112953 is a clinical study titled "Intraoperative Transesophageal Echocardiography Assessment of Portal Vein Flow and Renal Resistive Index As a Predictor of Acute Kidney Injury After Cardiac Surgery: A Prospective Observational Study". The purpose of this study is to better understand if transesophageal echocardiography during cardiac surgery can predict problems with kidney function after cardiac surgery.
What is the current status of trial NCT04112953?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2019-09-04. Estimated completion is 2022-11-15.
What conditions does trial NCT04112953 study?
This clinical trial studies the following conditions: AKI.
Who is sponsoring clinical trial NCT04112953?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04112953 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for AKI
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NO During CPB in Neonates to Reduce Risk of AKI
RECRUITING · Phase 3
-
Outpatient Recovery From Acute Kidney Injury Requiring Dialysis - 2
RECRUITING · NA
-
Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery
COMPLETED · Phase 2
-
Protection From Acute Kidney Injury (AKI) With Basis™ Treatment
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.